• Health & Medicine

Cancer Research UK leads global lung cancer drug trial

Cancer Research UK scientists in Oxford are trialling an experimental drug to treat lung cancer patients who have stopped responding to initial chemotherapy treatment. The trial will take place at the Oxford Radcliffe Hospitals NHS Trust. Cancer Research UK scientists in Oxford are trialling an experimental drug to treat lung cancer patients who have stopped responding to initial chemotherapy treatment. The trial will take place at the Oxford Radcliffe Hospitals NHS Trust.

29 March 2011

• Health & Medicine

Cancer Research Technology, The ICR and ZoBio BV sign deal to develop cancer drugs

Cancer Research Technology (CRT) and The Institute of Cancer Research (ICR) have signed a deal with Dutch drug discovery company, ZoBio BV, to discover and develop drugs to block a DNA repair target which may play a role in cancer cell survival. Cancer Research Technology (CRT) and The Institute of Cancer Research (ICR) have signed a deal with Dutch drug discovery company, ZoBio BV, to discover and develop drugs to block a DNA repair target which may play a role in cancer cell survival.

10 March 2011

• Science & Technology
• Health & Medicine

Powerful online cancer drug discovery database unveiled

A powerful new cancer drug discovery database has been launched to speed up the process of bringing drugs from 'bench to bedside'. A powerful new cancer drug discovery database has been launched to speed up the process of bringing drugs from 'bench to bedside'.

29 November 2010

• Health & Medicine

Gene could predict breast cancer patients' response to tamoxifen

Scientists have identified a gene which could help predict whether a breast cancer patient will respond to taking tamoxifen. Scientists have identified a gene which could help predict whether a breast cancer patient will respond to taking tamoxifen.

13 October 2010

• Science & Technology
• Health & Medicine

Cancer Research UK and AstraZeneca sign deal to trial first-of-kind cancer drug

Cancer Research UK and Cancer Research Technology have reached an agreement with AstraZeneca to take compound AZD-3965, a first-of-its-kind experimental drug to potentially treat a range of cancers into clinical trial. Cancer Research UK and Cancer Research Technology have reached an agreement with AstraZeneca to take compound AZD-3965, a first-of-its-kind experimental drug to potentially treat a range of cancers into clinical trial.

13 September 2010

• Science & Technology
• Health & Medicine

CRT and ValiRx sign licensing deal to develop prostate cancer treatment

CANCER RESEARCH TECHNOLOGY has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer. CANCER RESEARCH TECHNOLOGY has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.

12 August 2010

• Health & Medicine

Breath test could help to detect cancer

A test using a patient's breath could be developed to detect lung, breast, bowel and prostate cancers, a team of scientists have discovered. A test using a patient's breath could be developed to detect lung, breast, bowel and prostate cancers, a team of scientists have discovered.

11 August 2010

• Science & Technology
• Health & Medicine

Cancer Research UK launches medicine manufacturing hub for life-saving research

Cancer Research UK's Drug Development Office marks the launch of its Biotherapeutics Development Unit (BDU) today with the manufacture of its first product - an antibody for treating a range of cancers. Cancer Research UK's Drug Development Office marks the launch of its Biotherapeutics Development Unit (BDU) today with the manufacture of its first product - an antibody for treating a range of cancers.

30 July 2010

• Science & Technology
• Health & Medicine

'Skills Swap' to exploit expertise for patient benefit

Cancer Research Technology (CRT) and Medical Research Council Technology (MRCT) will 'swap' medical discoveries to accelerate the translation of early scientific research into patient benefit. Cancer Research Technology (CRT) and Medical Research Council Technology (MRCT) will 'swap' medical discoveries to accelerate the translation of early scientific research into patient benefit.

13 July 2010

• Science & Technology
• Health & Medicine

UK-NZ collaboration to home in on new anti-cancer drug for leukaemia

Cancer Research Technology (CRT) - Cancer Research UK's development and commercialisation arm has teamed up with The University of Auckland to advance the discovery of new molecular targeted compounds for the treatment of leukaemia. Cancer Research Technology (CRT) - Cancer Research UK's development and commercialisation arm has teamed up with The University of Auckland to advance the discovery of new molecular targeted compounds for the treatment of leukaemia.

22 April 2010

• Health & Medicine

Call for nominations as Cancer Research UK announce new prestigious awards

Cancer Research UK today (Tuesday) announced the launch of three new prestigious awards that will recognise world leading cancer researchers and the scientists of tomorrow. Cancer Research UK today (Tuesday) announced the launch of three new prestigious awards that will recognise world leading cancer researchers and the scientists of tomorrow.

30 March 2010

• Science & Technology
• Health & Medicine

Cancer Research UK launches groundbreaking research centre at Barts

A new cancer centre, launched today, puts London at the forefront of cancer research. A new cancer centre, launched today, puts London at the forefront of cancer research.

23 February 2010